| S1990 |
Capsaicin(Vanilloid)
|
Capsaicin(Vanilloid) is an active component of chili peppers, which are plants belonging to the genus Capsicum. It is a TRPV1 agonist with an EC50 of 0.29 μM in HEK293 cells. This compound is a mixture of Capsaicin and Dihydrocapsaicin.
|
-
J Biomed Sci, 2025, 32(1):47
-
Int J Mol Sci, 2025, 26(1)380
-
Biol Pharm Bull, 2025, 48(6):769-781
|
|
| S6657 |
2-APB (2-Aminoethyl Diphenylborinate)
|
2-Aminoethyl Diphenylborinate (2-APB) is an IP3 receptor inhibitor and regulates IP3-induced calcium release. It also inhibits the SOC channel activity and, at higher concentrations, inhibits TRP channel.
|
-
Cell Prolif, 2025, e70120.
-
PLoS Pathog, 2025, 21(1):e1012872
-
Liver Int, 2025, 45(10):e70341
|
|
| S7999 |
SKF96365
|
SKF96365, originally identified as a blocker of receptor-mediated calcium entry, is widely used diagnostically, as a blocker of transient receptor potential canonical type (TRPC) channels.
|
-
Exp Lung Res, 2025, 51(1):23-37
-
J Vis Exp, 2025, (224)
-
Research Square, 2024, 10.21203/rs.3.rs-3863076/v1
|
|
| S7115 |
AMG-517
|
AMG 517 is a potent and selective TRPV1 antagonist, and antagonizes capsaicin, proton, and heat activation of TRPV1 with IC50 of 0.76 nM, 0.62 nM and 1.3 nM, respectively.
|
-
Mucosal Immunol, 2024, S1933-0219(24)00006-0
-
Front Immunol, 2024, 15:1477072
-
iScience, 2023, 26(5):106749
|
|
| S8367 |
GSK2193874
|
GSK2193874 is an orally active, potent, and selective blocker of transient receptor potential vanilloid 4 (TRPV4) with IC50 values of 0.04 and 0.002 μM for hTRPV4 and rTRPV4, respectively.
|
-
Brain Stimul, 2025, 18(5):1455-1469
-
Int J Oral Sci, 2024, 16(1):3
-
iScience, 2023, 26(5):106749
|
|
| S8107 |
GSK1016790A
|
GSK1016790A (GSK101) is a novel, potent activator of TRPV4 (transient receptor potential vanilloid 4) with EC50 of 34nM in choroid plexus epithelial cells.
|
-
Brain Stimul, 2025, 18(5):1455-1469
-
Am J Physiol Lung Cell Mol Physiol, 2024, 326(3):L252-L265
-
iScience, 2023, 26(5):106749
|
|
| S2918 |
HC-030031
|
HC-030031 (TOSLAB 829227) is a selective TRPA1 channel blocker that antagonizes AITC- and formalin-evoked calcium influx with IC50 of 6.2 μM and 5.3 μM respectively.
|
-
Int J Mol Sci, 2025, 26(3)1385
-
Lipids Health Dis, 2023, 22(1):6
-
Mol Pain, 2023, 19:17448069231158290
|
|
| S8137 |
Capsazepine
|
Capsazepine acts as a competitive antagonist of capsaicin and a transient receptor potential vanilloid type 1(TRPV1) antagonist. If you want to do cell experiments, please select batch 01.
|
-
Biol Pharm Bull, 2025, 48(6):769-781
-
J Ethnopharmacol, 2024, 337(Pt 2):118882
-
Sci Adv, 2023, 9(27):eadg9593
|
|
| S9849 |
EIPA (L593754)
|
EIPA (L593754; MH 12-43) acts as an inhibitor of macropinocytosis and sodium-hydrogen exchangers(NHE) (IC50=0.033μg/mL). EIPA blocks the activity of Na(+)/H(+) exchanger, which are plasma membrane proteins implicated in all forms of macropinocytosis.
|
-
J Adv Res, 2025, S2090-1232(25)00267-X
-
J Nanobiotechnology, 2025, 23(1):173
-
iScience, 2025, 28(2):111830
|
|
| S2773 |
SB705498
|
SB705498 is a TRPV1 antagonist for hTRPV1, antagonizes capsaicin, acid, and heat activation of TRPV1 with IC50 of 3 nM, 0.1 nM and 6 nM, shows a degree of voltage dependence, exhibits >100-fold selectivity for TRPV1 over TRPM8. Phase 2.
|
-
Oxid Med Cell Longev, 2022, 2022:8096009
-
IUBMB Life, 2022, 10.1002/iub.2605
-
Biogerontology, 2016, 17(5-6):907-920
|
|